Micropulse Laser Photocoagulation in Diabetic Macular Edema
ConditionDiabetic Macular Edema
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorSohag University
About this trial
To assess the safety and efficacy of 532 nm subthreshold micropulse laser 5 % duty cycle compared with 15 % duty cycle in treatment of diabetic macular edema .
Eligibility criteria
Qualifiers
Are More than 18 years old .
have diabetic macular edema with a central retinal thickness < 400 um .
have best corrected visual acuity between 6/18 and 6/60 .
Disqualifiers
Previous lasered retina , Anti - VEGF injection or vitrectomy .
Extensive Macular ischemia on FFA .
Media opacity .
Associated ocular pathology as glaucoma, CNV (choroidal neovascularization ) , AMD (age related macular degenerations ), epiretinal membrane vitreomacular traction and retinal vein occlusion .
Trial design
Treatments tested in this trial
- micropulse laser photocoagulation
- micropulse laser photocoagulation
Treatment groups
50 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov